Научная литература
booksshare.net -> Добавить материал -> Медицина -> Насонов Е.Л. -> "Антифосфолипидный синдром" -> 39

Антифосфолипидный синдром - Насонов Е.Л.

Насонов Е.Л. Антифосфолипидный синдром — М.: Литтерра, 2004. — 440 c.
ISBN 5-98216-010-5
Скачать (прямая ссылка): antisindrom2004.pdf
Предыдущая << 1 .. 33 34 35 36 37 38 < 39 > 40 41 42 43 44 45 .. 184 >> Следующая

40. Roubey RAS, Eisenberg RA, Harper MF, Winfield JB. "Anticardiolipin" antibodies recognize ?2-glycoprotein I in the absence of phospho-lipid. Importance of antigen density and bivalent binding. J Immunol 1995; 154: 954—960.
41. Tincani A, Spatola L, Pratt E, et al. The anti-?2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreac-tive low-affinity autoantibodies directed to epitope located on native ?2-glycoprotein I and preserved during species evolution. J Immunol 1996; 157: 5732—5738.
42. Amengual O, Atsumi T, Koike T. Specificities, properties, and clinical significance of anti-prothrombin antibodies. Arthritis Rheum 2003; 48: 886—895.
43. de Groot PG, Derksen RHWM. The influence of antiphospholipid antibodies on the protein C pathway. In Hughes Syndrome, Antiphospho-lipid Syndrome. Edited by Khamashta MA. London: Springer—Verlag; 2000; 307—316.
44. Dahlback B. Physiological anticoagulation: resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923— 927.
45. Koike T, Hughes GRV. Binding of anticar-diolipin antibodies to protein C via beta 2 glyco-protein I: a possible mechanism in inhibitory effect of antiphospholipid antibodies on the protein C system. Clin Exp Immunol 1998, 112: 325—333.
46. Galli M, Ruggeri L, Barbui T. Differential effects of anti-beta 2 glycoprotein I and anti-pro-thrombin antibody on the anticoagulant activity of
activated protein C. Blood 1998, 91: 1999— 2004.
47. Male C, Mitchell L, Julian J, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001; 97: 844— 849.
48. Ieko M, Sawada KI, Koike T, et al. The putative mechanism of thrombosis in antiphos-pholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anti-cardiolipin antibodies. Semin Thromb Hemost 1999; 25: 503— 507.
49. Esmon CT. The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. JAutoimmun 2000; 15:113—116.
50. Ames PR, Tommasino C, Iannaccone L, Brillante M, Cimino R, Brancaccio V. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibod-ies-a crucial role for acquired free protein S deficiency. Thromb Haemost 1996; 76: 190—194.
51. Crowther MA, Johnston M, Weitz J, Ginsberg JS. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus. Thromb Haemost 1996; 76: 689—691.
52. Shibata S, Harpel PC, Gharavi A, Rand J, Fillit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994; 83: 2532—2540.
53. Schousboe I, Rasmussen MS. Synchronized inhibition of the phospholipid mediated autoactivation of factor XII in plasma by beta2-glycoprotein I and anti-beta2-glycopro-tein I. Thromb Haemost 1995; 73: 798—804.
54. Jones DW, Gallimor MJ, MacKie IJ, et al. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. Br J Haematol 2000; 110: 721— 726.
55. Sugi T, Makino T: Plasma contact system, kallikrein/kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy. J Reprod Immunol 2000; 47: 169— 184.
56. Dueymes M, Levy Y, Ziporen L, Jamin C, Piette JC, Shoenfeld Y, Youinou P. Do some antiphospholipid antibodies target endothelial
SHS-OOO4.qxd 21.11.2006 16:56 Page 1003
ГЛАВА 5. Патогенетические механизмы антифосфолипидного синдрома
cells? Ann Med Interne (Paris). 1996; 147 (Suppl 1): 22—23.
57. Matsuda J, Gotoh M, Gohchi K, Kawasugi K, Tsukamoto M, Saitoh N. Anti-endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies. Br J Haematol 1997; 97: 227—232.
58. Navarro M, Cervera R, Teixido M, Reverter JC, Font J, Lopez Soto A, Monteagudo J, Escolar G, Ingelmo M. Antibodies to endothelial cells and to ?2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution. Br J Rheumatol 1996; 35: 523—528.
59. Le Tonqueze M, Salozhin K, Dueyems M, Nasonov E, Piette J-C, Youinou P. Role of ?2-gly-coprote in the antiphospholipid antibody binding to endothelial cells. Lupus, 1995; 7: 179—186.
60. Meroni PL, Raschi E, Camera M, Testoni C, Nicoletti F, Tincani A, Khamashta MA, Balestrieri G, Tremoli E, Hess DC. Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome. J Autoimmun. 2000; 15: 237—240.
61. Keying M, Simantov R, Jing-Chuan Z, et al. High affinity binding of ?2-glycoprotein I to human endothelial cells is mediated by Annexin II. J Biol Chem 2000; 20: 15541— 15548.
62. Afek A, Shoenfeld Y, Manor R, et al. Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in primary (Hughes) and secondary antiphospho-lipid syndrome. Lupus 1999; 8: 502— 507.
Предыдущая << 1 .. 33 34 35 36 37 38 < 39 > 40 41 42 43 44 45 .. 184 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed